In vitro panning of a targeting peptide to hepatocarcinoma from a phage display peptide library

Bing Du, Min Qian*, Zhongliang Zhou, Peng Wang, Lei Wang, Xiaoping Zhang, Miao Wu, Ping Zhang, Bing Mei

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

43 Scopus citations

Abstract

Phage display technology has been used as a powerful tool in the discovery of ligands specific to receptor(s) on the surface of a cancer cell and could also impact clinical issues including functional diagnosis and cell-specific drug delivery. After three rounds of in vitro panning and two rounds of reverse absorption, a group of phages capable of addressing BEL-7402 enormously were obtained for further analysis. Through a cell-based ELISA, immunofluorescence, FACS, and in vivo binding study, WP05 (sequence TACHQHVRMVRP) was demonstrated to be the most effective peptide in targeting four kinds of liver cancer cell lines (BEL-7402, BEL-7404, SMMC-7721, and HepG2), but not the normal liver cell line HL-7702. In conclusion, the peptide WP05 which was screened by in vitro phage display technology was proved to be a targeting peptide to several common hepatocellular carcinoma cell lines.

Original languageEnglish
Pages (from-to)956-962
Number of pages7
JournalBiochemical and Biophysical Research Communications
Volume342
Issue number3
DOIs
StatePublished - 14 Apr 2006

Keywords

  • Hepatocellular carcinoma
  • In vitro
  • Phage display library
  • Targeting peptides

Fingerprint

Dive into the research topics of 'In vitro panning of a targeting peptide to hepatocarcinoma from a phage display peptide library'. Together they form a unique fingerprint.

Cite this